IP Library › Granted Patent US 7,977,067
Granted Patent B2
US 7,977,067 · App. 11/007,886 · Granted Jul 12, 2011

Production of functional antibodies in filamentous fungi

Assignee: Danisco US Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,977,067
App. No.
11/007,886
Granted
Jul 12, 2011
Kind
B2
Abstract

Described herein are methods for the production of monoclonal antibodies in filamentous fungi host cells. The monoclonal antibodies are expressed as full-length fusion proteins that retain functional antigen binding and antibody-dependent cellular cytotoxicity capabilities. Improvements in the cleavage of the glucoamylase-light chain fusion protein to yield a mature antibody are also provided. The antibodies produced in filamentous fungi show equivalent pharmacokinetic disposition to antibodies produced in mammalian cells.

Claims (18)

1. A process for producing an immunoglobulin molecule or an immunologically functional immunoglobulin fragment comprising at least the variable domains of the immunoglobulin heavy and light chains, in a host filamentous fungus, comprising the steps of:

a. transforming said host with a first expression vector containing a fusion DNA construct encoding a first fusion polypeptide comprising, from a 5′ end of said DNA construct, first, second, third and fourth nucleic acids, wherein said first nucleic acid encodes a signal polypeptide functional as a secretory sequence in the host, said second nucleic acid encodes a secreted polypeptide or functional portion thereof normally secreted from a filamentous fungus, said third nucleic acid encodes a cleavable linker and said fourth nucleic acid encodes an immunoglobulin light chain or fragment thereof;

b. transforming said host with a second expression vector containing a fusion nucleic acid encoding a second fusion polypeptide comprising, from a 5′ end of said fusion nucleic acid, first, second, third and fourth nucleic acids, wherein said first nucleic acid encodes a signal polypeptide functional as a secretory sequence in the host, said second nucleic acid encodes a secreted polypeptide or functional portion thereof normally secreted from a filamentous fungus, said third nucleic acid encodes a cleavable linker and said fourth nucleic acid encodes an immunoglobulin heavy chain or fragment thereof;

c. growing said host under conditions which permit expression of said fusion DNA construct and said fusion nucleic acid sequences to cause the expression of the first fusion and the second fusion polypeptides; and

d. isolating said immunoglobulin molecule or immunologically functional immunoglobulin fragment comprising at least the variable domains of the immunoglobulin heavy and lights chains;

wherein the secreted polypeptide or functional portion thereof in (a) and (b) is glucoamylase, and the cleavable linker in (a) and (b) is cleavable by a native filamentous fungus protease, and

wherein the immunoglobulin or immunologically functional immunoglobulin fragment has an amino acid substitution N297Q in the heavy chain, and the immunoglobulin has reduced glycosylation due to the amino acid substitution N297Q in the heavy chain.

2. The process of claim 1 , wherein the immunoglobulin molecule or fragment thereof is secreted.

3. The process according to claim 1 , wherein the host filamentous fungus is an Aspergillus, Neurospora , or Fusarium.

4. The process according to claim 3 , wherein the host filamentous fungus is an Aspergillus.

5. The process according to claim 4 , wherein the host filamentous fungus is an Aspergillus niger.

6. The process according to claim 1 , wherein the immunoglobulin has a fungal glycosylation pattern.

7. The process according to claim 6 , wherein the immunoglobulin has a high mannose glycosylation pattern.

8. The process according to claim 1 , wherein the transformation of step a) and step b) is a co-transformation.

9. The process according to claim 1 , wherein the transformation of step a) and step b) are sequential transformations.

10. The host filamentous fungal cell transformed by the process of claim 1 .

11. The process according to claim 1 , wherein the cleavable linker in (a) and (b) is the KEX2 site.

12. The process according to claim 1 , wherein the host filamentous fungus is an Aspergillus, Neurospora, Fusarium, Trichoderma, Cephalosporium, Penicillium or Chrysosporium and wherein the secreted polypeptide or functional portion thereof in (a) and (b) is glucoamylase from Aspergillus niger.

Continuity (6)
Division 10418836 · Apr 17, 2003
Provisional Application 60373889 · Apr 18, 2002
Provisional Application 60411540 · Sep 18, 2002
Provisional Application 60411537 · Sep 18, 2002
Provisional Application 60452134 · Mar 4, 2003
Related Publication 20050158825A1 · Jul 21, 2005